News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,352 Results
Type
Article (1921)
Company Profile (2)
Press Release (67429)
Section
Business (21479)
Career Advice (9)
Deals (4556)
Drug Development (8156)
FDA (1803)
Job Trends (800)
News (37037)
Policy (3561)
Tag
Academia (92)
Alliances (8134)
Alzheimer's disease (119)
Antibody-drug conjugate (ADC) (8)
Approvals (1818)
Artificial intelligence (10)
Bankruptcy (8)
Best Places to Work (585)
Biosimilars (14)
Breast cancer (15)
Cancer (161)
Career advice (9)
Cell therapy (16)
Clinical research (6935)
Collaboration (65)
COVID-19 (182)
C-suite (9)
Data (139)
Diabetes (11)
Diagnostics (592)
Drug discovery (13)
Duchenne muscular dystrophy (7)
Earnings (7507)
Events (6895)
Executive appointments (40)
FDA (1898)
Funding (42)
Gene therapy (14)
GLP-1 (40)
Government (233)
Healthcare (1072)
Infectious disease (187)
Inflammatory bowel disease (14)
Intellectual property (8)
IPO (1616)
Job creations (240)
Job search strategy (9)
Layoffs (6)
Legal (948)
Liver cancer (15)
Lung cancer (27)
Lymphoma (9)
Manufacturing (25)
Medical device (1111)
Medtech (1112)
Mergers & acquisitions (3006)
Metabolic disorders (31)
Neuroscience (152)
NextGen: Class of 2025 (219)
Non-profit (61)
Northern California (109)
Obesity (13)
Ovarian cancer (7)
Pancreatic cancer (6)
Parkinson's disease (12)
Patents (12)
People (4934)
Phase I (1884)
Phase II (2895)
Phase III (2637)
Pipeline (61)
Postmarket research (241)
Preclinical (653)
Radiopharmaceuticals (22)
Rare diseases (22)
Real estate (599)
Regulatory (2547)
Research institute (91)
Schizophrenia (6)
Series A (11)
Southern California (102)
Startups (421)
United States (962)
Vaccines (20)
Date
Today (7)
Last 7 days (40)
Last 30 days (216)
Last 365 days (3195)
2025 (226)
2024 (3255)
2023 (3818)
2022 (7015)
2021 (6378)
2020 (5881)
2019 (3867)
2018 (3013)
2017 (3569)
2016 (3174)
2015 (4030)
2014 (3020)
2013 (2601)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (79)
Arizona (7)
Asia (21259)
Australia (2423)
California (248)
Canada (185)
China (121)
Connecticut (11)
Europe (12327)
Florida (15)
Illinois (16)
India (7)
Japan (55)
Maryland (66)
Massachusetts (175)
Minnesota (24)
New Jersey (136)
New York (113)
North Carolina (50)
Northern California (109)
Pennsylvania (35)
South America (105)
Southern California (102)
Texas (17)
Utah (8)
Virginia (15)
69,352 Results for "hitgen ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program
August 22, 2024
·
4 min read
Press Releases
Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery, Upcoming Webinar Hosted by HitGen and Xtalks
July 17, 2024
·
3 min read
SGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
Shanghai Stock Exchange listed company HitGen Inc. announced that it has entered into a partnership with The Structural Genomics Consortium, a public-private partnership that supports the discovery of new medicines through open-access research.
September 28, 2023
·
3 min read
Business
Hox Therapeutics and Vernalis announce a drug discovery collaboration in oncology
Hox Therapeutics Ltd (“Hox”) a private biotechnology company developing highly targeted cancer therapies and Vernalis (R&D) Ltd (“Vernalis”), a fully owned subsidiary of HitGen Inc., are pleased to announce a collaboration to identify inhibitors against an undisclosed oncology target.
February 20, 2024
·
1 min read
Business
Daewoong and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
Shanghai Stock Exchange listed company HitGen Inc. announced that it has entered into a research collaboration agreement with DAEWOONG PHARMACEUTICAL Co., Ltd, a global healthcare group in the Republic of Korea, dedicated to improving the quality of patients’ lives.
November 13, 2022
·
2 min read
Press Releases
BlackfinBio Ltd announces the acquisition of Parkinson’s IP patent portfolio from OXB
January 8, 2025
·
1 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.
December 24, 2024
·
8 min read
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
Press Releases
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
January 24, 2025
·
5 min read
1 of 6,936
Next
